// App-Quantinova.ai

1264-216 : ANTITHROMBOTIC POTENCY OF TICAGRELOR VERSUS CLOPIDOGREL, WHEN ADMINISTERED WITH BIVALIRUDIN

Researchers

Presenter

  • Mohammad Urooj Zafar

Principal Investigators

  • David Vorchheimer

  • Mita P. Tewar

  • Chiara Giannarelli

  • Matteo Crippa

  • Samantha Sartori

  • David Rodriguez

  • Christina M. Gestal

  • Usman Baber

  • Juan Badimon

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Clopidogrel bisulfate

  • Ticagrelor

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved